Programme Thesis
Nexa funds bold, climate-health innovations across Africa, Latin America, and the Caribbean that translate climate-driven health risk signals (from heat, poor air quality, and changing mosquito ecology) into timely health service delivery actions, reducing health harms. It exists to bridge the gap between climate data and local health action, with a focus on scaling proven solutions.
Selection Criteria
Eligibility: Applicant organization must be incorporated or equivalent (any country) but implementation must occur in eligible countries in Africa, Latin America, or the Caribbean (see Appendix B). Innovation must directly address at least one focus area: (1) climate-informed early warning and monitoring systems, or (2) climate-responsive patient care delivery. For Transition to Scale: innovation must have been tested, proven effective, and ready for wider implementation. Funding amount: $250K-$2M USD, at partners' discretion based on maturity. Application must be submitted via Fluxx portal by deadline. Review priorities: likely include evidence of effectiveness, scalability potential, local health actor engagement, climate-health alignment, sustainability, and equity (e.g., reaching vulnerable populations).
Past Winners / Cohort Profiles
Past winners of Grand Challenges Canada programs (e.g., Saving Lives at Birth, Stars in Global Health) typically include social enterprises, NGOs, academic spin-offs, and local health-tech startups with proven pilots. For Nexa specifically, early cohorts (Proof of Concept) included innovations like mobile health tools for heat-health action plans, community-based surveillance for dengue, and air quality monitoring linked to health alerts. Named examples are not on the page, but archetypes are organizations with a tested product and a clear pathway to scale in LMICs.
Ideal Candidate Fingerprint
The platonic ideal applicant is an incorporated organization (social enterprise, NGO, or company) with a proven, evidence-based climate-health innovation that has been piloted in an eligible country and is ready to scale. They have strong partnerships with local health actors (ministries, clinics, community health workers), a clear implementation plan, and a sustainable business model. They can articulate how their solution turns climate risk signals into concrete health actions, with measurable health impact.
Recommended Framing
Eniola's strongest angle is to position his e-pharmacy/telepharmacy platform as a climate-responsive patient care delivery innovation, specifically addressing heat-related medication storage and air-quality-triggered respiratory conditions. He can leverage his computational modeling skills to propose a climate-risk-integrated platform that uses local climate data (heat, air quality) to trigger automated patient alerts and medication management, enabling local health actors to act on climate signals. However, he must partner with an eligible incorporated organization (e.g., a Nigerian health-tech company or NGO) or incorporate one, as he is an independent researcher.
Watch Out
Independent researcher status is a hard blocker: applicant must be an incorporated organization or equivalent. No evidence of organizational incorporation. The platform is not yet proven or tested at scale; Transition to Scale requires proven effectiveness. The current focus on e-pharmacy/telepharmacy may not directly address climate-health focus areas unless explicitly reframed. Deadline is August 12, 2026, but Proof of Concept applications are no longer accepted, so only Transition to Scale is possible, which requires prior evidence.